362PD TAX-TORC: An investigator initiated phase I study combining the dual mTORC1/2 inhibitor AZD2014 in combination with weekly paclitaxel in high-grade serous ovarian cancer
Banerji U, Basu B, Spicer J, Wilson R, Hall E, Sundar R, Kumar S, Wu Y, Coyle V, Carreira S, Parmar M, Dawes J, Banerjee S, de Bono J. 362PD TAX-TORC: An investigator initiated phase I study combining the dual mTORC1/2 inhibitor AZD2014 in combination with weekly paclitaxel in high-grade serous ovarian cancer. Annals Of Oncology 2016, 27: vi115. DOI: 10.1093/annonc/mdw368.05.Peer-Reviewed Original ResearchHigh-grade serous ovarian cancerMTORC1/2 inhibitor AZD2014Phase I studySerous ovarian cancerOvarian cancer